Cargando…

How Do We Start Palliative Care for Patients With End-Stage Liver Disease?

Patients with end-stage liver disease undergo repetitive patterns of recovery and deterioration and are burdened with uncertainty. Although quality of life is low in patients with end-stage liver disease and their family members, few studies have been conducted to identify what palliative care shoul...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sookyung, Lee, Kyunghwa, Kim, Changhwan, Choi, Jahyun, Kim, Sanghee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963522/
https://www.ncbi.nlm.nih.gov/pubmed/34269708
http://dx.doi.org/10.1097/SGA.0000000000000611
_version_ 1784678006347792384
author Kim, Sookyung
Lee, Kyunghwa
Kim, Changhwan
Choi, Jahyun
Kim, Sanghee
author_facet Kim, Sookyung
Lee, Kyunghwa
Kim, Changhwan
Choi, Jahyun
Kim, Sanghee
author_sort Kim, Sookyung
collection PubMed
description Patients with end-stage liver disease undergo repetitive patterns of recovery and deterioration and are burdened with uncertainty. Although quality of life is low in patients with end-stage liver disease and their family members, few studies have been conducted to identify what palliative care should be provided for them. This integrative review aimed to explore palliative care for patients with end-stage liver disease, focusing on the components and outcome measurements for further research. After searching for studies on palliative care for end-stage liver disease published between 1995 and 2017, 12 studies that met the inclusion criteria were analyzed. The common components of palliative care for patients with liver disease were: (a) an interdisciplinary approach, (b) early palliative care, (c) discussion goals of care with patient and family members, (d) symptom management, and (e) psychosocial support. It was reported that patients who were provided palliative care had improved itching, well-being, appetite, anxiety, fatigue, and depression, increased the number of do-not-resuscitate orders, palliative care consultations, and decreased length of stay. These findings could guide the development of palliative care for end-stage liver disease patients.
format Online
Article
Text
id pubmed-8963522
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-89635222022-04-01 How Do We Start Palliative Care for Patients With End-Stage Liver Disease? Kim, Sookyung Lee, Kyunghwa Kim, Changhwan Choi, Jahyun Kim, Sanghee Gastroenterol Nurs Features Patients with end-stage liver disease undergo repetitive patterns of recovery and deterioration and are burdened with uncertainty. Although quality of life is low in patients with end-stage liver disease and their family members, few studies have been conducted to identify what palliative care should be provided for them. This integrative review aimed to explore palliative care for patients with end-stage liver disease, focusing on the components and outcome measurements for further research. After searching for studies on palliative care for end-stage liver disease published between 1995 and 2017, 12 studies that met the inclusion criteria were analyzed. The common components of palliative care for patients with liver disease were: (a) an interdisciplinary approach, (b) early palliative care, (c) discussion goals of care with patient and family members, (d) symptom management, and (e) psychosocial support. It was reported that patients who were provided palliative care had improved itching, well-being, appetite, anxiety, fatigue, and depression, increased the number of do-not-resuscitate orders, palliative care consultations, and decreased length of stay. These findings could guide the development of palliative care for end-stage liver disease patients. Wolters Kluwer Health, Inc. 2022-03 2021-07-13 /pmc/articles/PMC8963522/ /pubmed/34269708 http://dx.doi.org/10.1097/SGA.0000000000000611 Text en © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Gastroenterology Nurses and Associates https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Features
Kim, Sookyung
Lee, Kyunghwa
Kim, Changhwan
Choi, Jahyun
Kim, Sanghee
How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
title How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
title_full How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
title_fullStr How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
title_full_unstemmed How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
title_short How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
title_sort how do we start palliative care for patients with end-stage liver disease?
topic Features
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963522/
https://www.ncbi.nlm.nih.gov/pubmed/34269708
http://dx.doi.org/10.1097/SGA.0000000000000611
work_keys_str_mv AT kimsookyung howdowestartpalliativecareforpatientswithendstageliverdisease
AT leekyunghwa howdowestartpalliativecareforpatientswithendstageliverdisease
AT kimchanghwan howdowestartpalliativecareforpatientswithendstageliverdisease
AT choijahyun howdowestartpalliativecareforpatientswithendstageliverdisease
AT kimsanghee howdowestartpalliativecareforpatientswithendstageliverdisease